Sartorius Stedim Biotech Signs Private Label Agreement With Trace Analytics
- Exclusive global marketing rights for new glucose-lactate analyzer
- Expansion of SSB's PAT portfolio for biopharmaceutical processes
Sartorius Stedim Biotech (SSB), a leading international provider for the biotech and pharmaceutical industries, concluded a private label agreement with Trace Analytics, a leading provider of analyzing systems for online monitoring of biotech cultivation processes. This contract grants SSB exclusive global rights to market, distribute and service BioPAT Trace, the new online analyzing system.
BioPAT Trace is a glucose-lactate analyzer used for monitoring and controlling both pilotscale and process-scale fermentation and cell cultivation processes. The system measures the concentrations of the two analytes glucose and lactate simultaneously, in real time and online. BioPAT Trace can be integrated into either single-use or reusable stainless steel bioreactors and, thanks to its single-use sensors and microfluidic elements, is immediately ready to use. The system enables reliably sterile, automated sampling, by either filtration or dialysis, from the bioreactor.
Mario Becker, Director of Marketing, PAT & Automation at Sartorius, states: "With BioPAT Trace, we are expanding our PAT portfolio by an important component. The new glucose-lactate analyzer provides our customers with real-time information about their critical process parameters, helping them to further optimize and automate their processes."
Trace Analytics CEO Dr. Wolfgang Künnecke: "Sartorius as a leading technology provider in the pharmaceutical and biotech industries has sales and service structures in place across the globe. Through this alliance, we have found the perfect partner to enable us to serve the worldwide needs of our customers by providing the highest quality."
About Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of "turning science into solutions." Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 2,850 people, and in 2011 earned sales revenue of 477.3 million euros according to preliminary figures.
About Trace Analytics
TRACE Analytics GmbH is a leading provider of on-line analysis systems for biotech applications in research, development and production. Based on our own research and development work, robust and easy to maintain devices and sterile process connections are realized for monitoring and control of complex fermentation processes under continuous measurement conditions. TRACE is a reliable supplier of instruments, consumables and services to the world's leading biopharmaceutical companies as well as numerous universities and research labs.
SOURCE: Sartorius Stedim Biotech